Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Immunotherapy with monoclonal antibodies in lung cancer of mice, oxidative stress and other biological events

  • Barreiro, Esther|||0000-0003-2708-3443
  • Tang, Jun|||0000-0001-9141-3537
  • Ramis-Cabrer, Daniel.|||0000-0001-7793-773X
  • Wang, Xuejie|||0000-0003-1398-3942
Background: Lung cancer (LC) is a major leading cause of death worldwide. Immunomodulators that target several immune mechanisms have proven to reduce tumor burden in experimental models through induction of the immune microenvironment. We hypothesized that other biological mechanisms may also favor tumor burden reduction in lung cancer-bearing mice treated with immunomodulators. Methods: Tumor weight, area, T cells and tumor growth (immunohistochemistry), oxidative stress, apoptosis, autophagy, and signaling (NF-κB and sirtuin-1) markers were analyzed (immunoblotting) in subcutaneous tumor of BALB/c mice injected with LP07 adenocarcinoma cells treated with monoclonal antibodies (CD-137, CTLA-4, PD-1, and CD-19, N = 9/group) and non-treated control animals. Results: Compared to non-treated cancer mice, in tumors of monoclonal-treated animals, tumor area and weight and ki-67 were significantly reduced, while T cell counts, oxidative stress, apoptosis, autophagy, activated p65, and sirtuin-1 markers were increased. Conclusions: Immunomodulators elicited a reduction in tumor burden (reduced tumor size and weight) through decreased tumor proliferation and increased oxidative stress, apoptosis, autophagy, and signaling markers, which may have interfered with the immune profile of the tumor microenvironment. Future research should be devoted to the elucidation of the specific contribution of each biological mechanism to the reduced tumor burden.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Is iron deficiency modulating physical activity in COPD?

  • Martín-Ontiyuelo, Clara
  • Rodó-Pin, Anna
  • Sancho-Muñoz, Antonio
  • Martinez-Llorens, Juana María
  • Admetlló, Mireia|||0000-0002-4315-5534
  • Molina, Lluis
  • Gea Guiral, Joaquim
  • Barreiro, Esther|||0000-0003-2708-3443
  • Chiaradía, Diego A. Rodríguez
There is evidence that iron plays a key role in the adequate functioning of skeletal muscle. While it has been demonstrated that nonanemic iron deficiency (NAID) affects exercise tolerance and response to exercise training in patients with COPD, the impact on daily physical activities (DPAs) remains unknown. Eighteen COPD patients with NAID (ferritin <100 ng/mL or ferritin 100-299 ng/mL with a transferrin saturation <20%) and 18 COPD patients without this abnormality, matched for age, gender, and the degree of airflow limitation (control group), were enrolled to the study. The primary outcome was the level of DPA assessed by accelerometers. Patients were (mean [SD]) 66 (7) years and were mostly male (70%) and former smokers (52%). Their forced expiratory volume at 1 second was 41 (16)% predicted, carbon monoxide diffusing capacity was 47 (14)% predicted and oxygen arterial pressure reached 70 (11) mmHg. DPA and the number of steps per day were lower in NAID COPD patients compared with controls (physical activity level 1.39 vs 1.59, P <0.05; and 4,402 vs 6,975 steps/day, P <0.05, respectively). The percentage of patients with increased time spent sitting per day (>6 hours) was higher in patients with NAID compared with controls (73% vs 37%, P <0.05). In addition, the percentage of patients doing moderate to vigorous physical activity per day (>3 metabolic equivalents of task, at least 30 minutes) was lower in this group (66% vs 100%, P <0.05). The presence of iron deficiency was associated with reduced DPA in COPD patients. Further studies are needed to evaluate iron reposition and their impact on the level of physical activity in these patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Increased PARP Activity and DNA Damage in NSCLC Patients, influence of COPD

  • Tang, Jun
  • Curull Serrano, Víctor|||0000-0003-2709-7431
  • Wang, Xuejie|||0000-0003-1398-3942
  • Ampurdanés, Coral
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Pijuan, Lara|||0000-0002-9978-6933
  • Rodríguez-Fuster, Alberto|||0000-0002-4900-6126
  • Aguiló Espases, Rafael
  • Yélamos, José|||0000-0003-1195-1496
  • Barreiro, Esther|||0000-0003-2708-3443
(1) Background: Lung cancer (LC) is a major leading cause of death worldwide. Poly (ADP-ribose) polymerase (PARP)-1 and PARP-2 are key players in cancer. We aimed to assess PARP-1 and PARP-2 expression and activity and DNA damage in tumors and non-tumor lungs from patients with/without chronic obstructive pulmonary disease (COPD). (2) Methods: Lung tumor and non-tumor specimens were obtained through video-assisted thoracoscopic surgery (VATS) in LC patients with/without underlying COPD (two groups of patients, n = 15/group). PARP-1 and PARP-2 expression (ELISA), PARP activity (PARP colorimetric assay kit) and DNA damage (immunohistochemistry) levels were identified in all samples. (3) Results: Both PARP-1 and PARP-2 expression levels were significantly lower in lung tumors (irrespective of COPD)compared to non-tumor specimens, while DNA damage and PARP activity levels significantly increased in lung tumors compared to non-tumor specimens only in LC-COPD patients. PARP-2 expression was positively correlated with smoking burden in LC-COPD patients. (4) Conclusions: In lung tumors of COPD patients, an overactivation of PARP enzyme was observed. A decline in PARP-1 and PARP-2 protein expression was seen in lung tumors irrespective of COPD. Other phenotypic features (airway obstruction) beyond cancer may account for the increase in PARP activity seen in the tumors of patients with underlying COPD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Immune cell subtypes and cytokines in lung tumor microenvironment, Influence of COPD

  • Tang, Jun
  • Ramis-Cabrer, Daniel|||0000-0001-7793-773X
  • Curull Serrano, Víctor|||0000-0003-2709-7431
  • Wang, Xuejie|||0000-0003-1398-3942
  • Qin, Liyun
  • Mateu-Jiménez, Mercè
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Pijuan, Lara|||0000-0002-9978-6933
  • Rodríguez-Fuster, Alberto|||0000-0002-4900-6126
  • Aguiló Espases, Rafael
  • Barreiro, Esther|||0000-0003-2708-3443
Background: The immune microenvironment plays a role in tumorigenesis. Chronic Obstructive Pulmonary Disease (COPD) is an independent risk factor for lung cancer (LC). We hypothesized that immune profile characterized by T regulatory (Treg), natural killer (NK), and plasma cells, as well as interleukin (IL)-10 and interferon-gamma, may differ within tumors of LC patients with/without COPD. Methods: Treg (anti-CD3 and anti-forkhead boxP3 antibodies), NK (anti-NCR1 antibody), IgG (anti-CD138-IgG antibody), IgA (anti-CD138-IgA antibody) using immunohistochemistry, and both IL-10 and interferon-gamma (ELISA) were quantified in tumor and non-tumor specimens (thoracotomy for lung tumor resection) from 33 LC-COPD patients and 20 LC-only patients. Results: Immune profile in tumor versus non-tumor specimens: Treg cell counts significantly increased in tumors of both LC and LC-COPD patients, while in tumors of the latter group, IgG-secreting plasma cells significantly decreased and IL-10 increased. No significant differences were seen in levels of NK cells, IgA-secreting cells, IgA/IgG, or interferon-gamma. Immune profile in tumors of LC-COPD versus LC: No significant differences were observed in tumors between LC-COPD and LC patients for any study marker. Conclusions: Immune cell subtypes and cytokines are differentially expressed in lung tumors, and the presence of COPD elicited a decline in IgG-secreting plasma cell levels but not in other cell types.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Do redox balance and inflammatory events take place in mild bronchiectasis? A hint to clinical implications

  • Qin, Liyun
  • Guitart, Maria|||0000-0003-2957-7404
  • Admetlló, Mireia|||0000-0002-4315-5534
  • Esteban-Cucó, Sandra|||0000-0002-3574-2720
  • Maiques, José María|||0000-0002-4200-3344
  • Xia, Yingchen|||0000-0001-5697-7222
  • Zha, Jianhua
  • Carbullanca, Santiago
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Wang, Xuejie|||0000-0003-1398-3942
  • Barreiro, Esther|||0000-0003-2708-3443
We hypothesized that in mild bronchiectasis patients, increased systemic inflammation and redox imbalance may take place and correlate with clinical parameters. In plasma samples from patients with very mild bronchiectasis, inflammatory cells and molecules and redox balance parameters were analyzed. In the patients, lung function and exercise capacity, nutritional status, bacterial colonization, and radiological extension were assessed. Correlations between biological and clinical variables were determined. Compared to healthy controls, levels of acute phase reactants, neutrophils, IgG, IgA, myeloperoxidase, protein oxidation, and GSH increased and lung function and exercise capacity were mildly reduced. GSH levels were even greater in ex-smoker and Pseudomona-colonized patients. Furthermore, radiological extension inversely correlated with airway obstruction and, disease severity, and positively correlated with neutrophil numbers in mild bronchiectasis patients with no nutritional abnormalities. In stable patients with mild bronchiectasis, several important inflammatory and oxidative stress events take place in plasma. These findings suggest that the extension of bronchiectasis probably plays a role in the development of redox imbalance and systemic inflammation in patients with mild bronchiectasis. These results have therapeutic implications in the management of bronchiectasis patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Systemic profiles of micrornas, redox balance, and inflammation in lung cancer patients, influence of copd

  • Qin, Liyun
  • Guitart, Maria|||0000-0003-2957-7404
  • Curull Serrano, Víctor|||0000-0003-2709-7431
  • Sánchez Font, Albert|||0000-0003-1026-7908
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Tang, Jun
  • Admetlló, Mireia|||0000-0002-4315-5534
  • Barreiro, Esther|||0000-0003-2708-3443
Lung cancer (LC) risk increases in patients with chronic respiratory diseases (COPD). MicroRNAs and redox imbalance are involved in lung tumorigenesis in COPD patients. Whether systemic alterations of those events may also take place in LC patients remains unknown. Our objectives were to assess the plasma levels of microRNAs, redox balance, and cytokines in LC patients with/without COPD. MicroRNAs (RT-PCR) involved in LC, oxidized DNA, MDA-protein adducts, GSH, TEAC, VEGF, and TGF-beta (ELISA) were quantified in plasma samples from non-LC controls (n = 45), LC-only patients (n = 32), and LC-COPD patients (n = 91). In LC-COPD patients compared to controls and LC-only, MDA-protein adduct levels increased, while those of GSH decreased, and two patterns of plasma microRNA were detected. In both LC patient groups, miR-451 expression was downregulated, while those of microRNA-let7c were upregulated, and levels of TEAC and TGF-beta increased compared to the controls. Correlations were found between clinical and biological variables. A differential expression profile of microRNAs was detected in patients with LC. Moreover, in LC patients with COPD, plasma oxidative stress levels increased, whereas those of GSH declined. Systemic oxidative and antioxidant markers are differentially expressed in LC patients with respiratory diseases, thus implying its contribution to the pathogenesis of tumorigenesis in these patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Phenotypic clustering in non-cystic fibrosis bronchiectasis patients, The role of eosinophils in disease severity

  • Wang, Xuejie|||0000-0003-1398-3942
  • Villa, Carmen
  • Dobarganes, Yadira
  • Olveira, Casilda|||0000-0002-6912-7400
  • Girón, Rosa|||0000-0001-7094-0848
  • García Clemente, Marta|||0000-0003-0463-5946
  • Máiz, Luis
  • Sibila, Oriol|||0000-0002-4833-6713
  • Golpe, Rafael|||0000-0002-3759-5322
  • Menéndez, Rosario
  • Rodríguez López, Juan|||0000-0003-0089-9768
  • Prados, Concepción
  • Martínez García, Miguel Ángel|||0000-0002-7321-1891
  • Rodriguez Hermosa, Juan Luis|||0000-0003-0552-2484
  • de la Rosa Carrillo, David|||0000-0003-0753-1771
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Garcia-Ojalvo, Jordi|||0000-0002-3716-7520
  • Barreiro, Esther|||0000-0003-2708-3443
Whether high blood eosinophil counts may define a better phenotype in bronchiectasis patients, as shown in chronic obstructive pulmonary disease (COPD), remains to be investigated. Dif-ferential phenotypic characteristics according to eosinophil counts were assessed using a biostatistical approach in a large cohort study from the Spanish Online Bronchiectasis Registry (RIBRON). The 906 patients who met the inclusion criteria were clustered into two groups on the basis of their eosinophil levels. The potential differences according to the bronchiectasis severity index (BSI) score between two groups (Mann-Whitney U test and eosinophil count threshold: 100 cells/µL) showed the most balanced cluster sizes: above-threshold and below-threshold groups. Patients above the threshold exhibited significantly better clinical outcomes, lung function, and nutritional status, while showing lower systemic inflammation levels. The proportion of patients with mild disease was higher in the above-threshold group, while the below-threshold patients were more severe. Two distinct clinical phenotypes of stable patients with non-cystic fibrosis (CF) bronchiectasis of a wide range of disease severity were established on the basis of blood eosinophil counts using a biostatistical approach. Patients classified within the above-threshold cluster were those exhibiting a mild disease, significantly better clinical outcomes, lung function, and nutritional status while showing lower systemic inflammatory levels. These results will contribute to better characterizing bronchiectasis patients into phenotypic profiles with their clinical implications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Differences in nutritional status and inflammatory biomarkers between female and male patients with bronchiectasis, A large-cohort study

  • Wang, Xuejie|||0000-0003-1398-3942
  • Villa, Carmen
  • Dobarganes, Yadira
  • Olveira, Casilda|||0000-0002-6912-7400
  • Girón, Rosa|||0000-0001-7094-0848
  • García Clemente, Marta|||0000-0003-0463-5946
  • Maíz, Luis
  • Sibila, Oriol|||0000-0002-4833-6713
  • Golpe, Rafael|||0000-0002-3759-5322
  • Menéndez, Rosario
  • Rodríguez López, Juan|||0000-0003-0089-9768
  • Prados, Concepción
  • Martínez García, Miguel Ángel|||0000-0002-7321-1891
  • Rodriguez Hermosa, Juan Luis|||0000-0003-0552-2484
  • de la Rosa Carrillo, David|||0000-0003-0753-1771
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Barreiro, Esther|||0000-0003-2708-3443
We hypothesized that systemic inflammatory and nutritional parameters may differ between male and female patients with non-CF bronchiectasis. In a large patient cohort from the Spanish Online Bronchiectasis Registry (RIBRON), clinical features, systemic inflammatory and nutritional parameters were analyzed in male and female patients with bronchiectasis. Lung func-tion, disease severity using several scores, nutritional status, systemic inflammatory parameters, and multivariate regression analyses were performed to identify differences between male and female patients in the target variables. The number of female patients included in the registry was greater than male patients and they had a less severe disease as measured by all three indices of disease severity, a lower degree of airway obstruction, worse diffusion capacity and airway trapping, better nutritional parameters, and lower levels of inflammatory biomarkers. Multivariate regression analysis evidenced that strong relationships were found between female gender and the following variables: total numbers of leukocytes and neutrophils, hemoglobin, hematocrit, creatinine, and body mass index (BMI). Multivariate regression analyses evidenced that nutritional parameters and inflammatory biomarkers may be reliable indicators of gender-related differences in patients with non-CF bronchiectasis. These findings deserve further attention in follow-up investigations in which the potential predictive value of those biomarkers should be thoroughly explored.